financing

News
abcuro

Abcuro raises $155m for KLRG1 drug trial

Abcuro has raised $155 million in an oversubscribed second financing round that will fund its phase 2/3 trial of lead drug ABC008 for the treatment of inclusion body myosi

News
UK life sciences

Biotech investment in UK ticks up in Q2

Despite the economic downturn, UK life sciences companies raised a healthy £382 million ($486 million) in new financing in the second quarter of the year, with venture cap